Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening

Huizhen Ge, Lizeng Peng, Zhou Sun, Huanxiang Liu, Yulin Shen, Xiaojun Yao

Open source

DOI: 10.3389/fphar.2022.850855
Published: 2022-03-14
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2022.850855,
  title = {Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening},
  author = {Huizhen Ge and Lizeng Peng and Zhou Sun and Huanxiang Liu and Yulin Shen and Xiaojun Yao},
  year = {2022},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2022.850855},
  url = {https://doi.org/10.3389/fphar.2022.850855}
}

RIS

TY  - JOUR
TI  - Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening
AU  - Huizhen Ge
AU  - Lizeng Peng
AU  - Zhou Sun
AU  - Huanxiang Liu
AU  - Yulin Shen
AU  - Xiaojun Yao
PY  - 2022
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2022.850855
UR  - https://doi.org/10.3389/fphar.2022.850855
ER  -

APA

Ge, H., Peng, L., Sun, Z., Liu, H., Shen, Y., & Yao, X. (2022). Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.850855

Source records

crossref · retrieved 2026-09-25T01:21:03.367Z